In addition to inferior overall response rates compared with B-NHL, PTCLs also have inferior complete remission (CR) rates, poor progression-free survival (PFS) and overall survival (OS), even in the more favourable anaplastic large-cell lymphoma (ALCL), anaplastic lymphoma kinase (ALK)-positive subtype [1]. Here, ALK is linked to anaplastic large cell lymphoma.